Eco-summit for islands is held

16 October 2012 Last updated at 11:40 ET

More than 30 islands and regions are being represented at a summit on the Isle of Wight to discuss self-sufficiency and sustainability.

The two-day Global Ecoislands Summit 2012 involves community leaders, government ministers and technology giants.

The aim is for those communities involved to achieve self-sufficiency in energy, water and fuel by 2020.

Minister of State for Energy, John Hayes, will give the keynote address.

The islands and regions represented include the Isle of Wight, Isle of Man, Isle of Eigg, Jersey, Eastleigh, Fareham, Winchester, Frome, Brighton and Hove, 15 Scottish islands, Bornholm in Denmark and Tobago.

Ecoisland was formed on the Isle of Wight in 2008 and its aim is for the island to become the first sustainable region in Britain.

Some of its work includes creating a "food hub" to collect and distribute locally produced food and achieving zero waste to landfill.

It has more than 65 national partners, including IBM and Scottish and Southern Energy.

Ecoisland founder and chief executive, David Green, said the aim of the summit was to make the world "a cleaner, greener place".

More here:

Eco-summit for islands is held

Matchpack: Faroe Islands v Republic of Ireland

TEAM NEWS

The Faroes will seek to close down space in the midfield area. Joan Simun Edmundsson is set to lead the attack. Captain Frodi Benjaminsen and Christian Holst will also be handed key roles.

Stephen Kelly is set to start on the bench despite being unhappy, but Robbie Keane returns after missing the Germany match due to an achilles injury. Stoke City full-back Marc Wilson and Manchester United winger Robbie Brady both start as Stephen Ward, Keith Fahey and Simon Cox drop out from the 6-1 loss to Germany.

Republic of Ireland (4-4-2): Westwood (Sunderland); Coleman (Everton), OShea (Sunderland), ODea (Toronto FC), Wilson (Stoke); Brady (Manchester United), Andrews (Bolton), McCarthy (Wigan), McGeady (Spartak Moscow); Keane (LA Galaxy), Walters (Stoke).

MANAGER QUOTES

Lars Olsen (Faroe Islands): "When you lose 6-1 at home in a country like Ireland, of course you will be under pressure. We know Ireland are the favourites tomorrow, as Sweden were, but we will try to do our best. The Faroe Islands are a small team and almost every team we are playing against will be the favourites against us. It's a new team, the coach from Ireland, Trapattoni, is a very old guy in the game and I am sure he has told the players, 'Okay, now we start a new game, you have to do your best''."

Giovanni Trapattoni (Republic of Ireland): "Every manager has moments when he loses. After the Euros, we have lost only one game to Germany, the second team in the world. Its no problem.

MATCH FACTS

Republic of Ireland and Faroe Islands have only been drawn together once before. Ireland won both meetings in 2006 World Cup qualification, scoring four and conceding none.

Ireland are unbeaten in 18 away games (excluding games played on neutral venues),

Here is the original post:

Matchpack: Faroe Islands v Republic of Ireland

Islands in the Aegean Sea

Part of the Mediterranean climate, the islands in the Aegean Sea reach temperatures in the dry summer in the high 80s to 90s, cooling down to the 40s and 50s in the wet winter. The surface temperature of the Aegean in the summer ranges from 70 degrees in the north to 80 degrees in the south, making it comfortable for summertime swimming.

As for those thousands of islands, what differentiates them? The vast majority of the Aegean islands belong to Greece while a small number belong to Turkey. They range in size from the largest, Crete, at over 3,000 sq. mi. down through Delos at only 1.5 sq. mi. to even tinier islets, mostly uninhabited. Below, and in the referenced lists, are snippets about each of the larger and more frequently visited islands in the Aegean.

The two largest islands in the Aegean Sea are the Greek islands of Crete and Euboea. The other Aegean islands are generally divided into 5 geographic areas as described below.

Crete 3,224 sq. mi.; population 624,000

Forming the southern border of the Aegean Sea, Crete is the largest and most populous of the Greek Islands. Filled with ancient ruins and historical sites, Crete also offers excellent hiking opportunities, especially in the Samaria Gorge, as well as stunning beaches and coves.

Euboea (or Evia) 1,411 sq. mi.; population 220,000

A long, narrow island separated by the Euripus Strait from the eastern shore of mainland Greece, Euboea is often thought of as part of the mainland itself. From a tourism perspective, it is best known for the thermal hot springs at Edipsos, for the beachside resort at the modern town of Eretria on the site of the ancient city of the same name, still being excavated, and as a weekend seaside getaway for Athenians.

The Sporades

A tight group of islands off the north coast of Euboea, the Sporades incorporate about 30 islands including the main islands of Skiathos, Skopelos, Skyros, and Alonnisus.

Saronic Islands

Read the original post:

Islands in the Aegean Sea

23andMe Names Christine Castro, Neil Rothstein and Jonathan Ward to Leadership Positions

MOUNTAIN VIEW, Calif., Oct. 16, 2012 /PRNewswire/ --Today 23andMe, the leading personal genetics company, announces the appointment of Christine Castro as Vice President Communications, Neil Rothstein as Vice President Marketing, and Jonathan Ward as Vice President Strategic Alliances joining the company's executive leadership team.

As Vice President, Communications, Chris Castro is responsible for the company's corporate communications, media relations and investor relations initiatives. Prior to joining 23andMe, Chris served as Senior Vice President, Corporate Relations, for Genentech, as well as Chief Communications Officer for Yahoo! Inc. and Vice President, Corporate Communications for The Walt Disney Company. Chris has a Bachelor of Arts degree in journalism and a Master of Arts degree in communications management, both from the University of Southern California.

As VP Marketing, Neil Rothstein is responsible for the marketing, branding and customer acquisition activities of the company. Prior to joining 23andMe, Neil worked at Netflix for 11 years most recently serving as VP, Online Marketing where he led the company's global online marketing activities across the US, Canada, Latin America, UK, and Ireland. Neil has also had roles withRateItAll, ESPN, and the Atlanta Committee for the Olympic Games. Neil received an MBA from the Gouizueta Business School at Emory University anda BA in Economics from Brandeis University.

Serving as Vice President, Strategic Alliances, Jonathan Ward is responsible for the company's strategic partnerships. Prior to joining 23andMe, Jonathan served most recently as interim Chief Marketing Officer at eHarmony.com and held a variety of marketing and business development roles during his eight-year tenure there. Jonathan has also held marketing and business development roles at America Online, McKinsey & Company as well as Ogilvy, Adams & Rinehart. Jonathan has a Bachelor of Arts degree in English from Williams College and holds a Masters in management from the J.L. Kellogg School of Management at Northwestern University.

"The addition of these seasoned executives to our management team is essential to helping us manage our growth and continuing to expand the consumer genetics market,"said Anne Wojcicki, 23andMe CEO and co-founder. "I am thrilled to be working with such an experienced and innovative team."

About 23andMe23andMe, Inc. is the leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service enables individuals to gain deeper insights into their ancestry and inherited traits. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research. 23andMe, Inc., was founded in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science. More information is available at http://www.23andme.com.

Here is the original post:

23andMe Names Christine Castro, Neil Rothstein and Jonathan Ward to Leadership Positions

Human Life Span Took Huge Jump in Past Century

This article was updated at 7:19 p.m. ET.

Humans are living longer than ever, a life-span extension that occurred more rapidly than expected and almost solely from environmental improvements as opposed to genetics, researchers said today (Oct. 15).

Four generations ago, the average Swede had the same probability of dying as a hunter-gatherer, but improvements in our living conditions through medicine, better sanitation and clean drinking water (considered "environmental" changes) decreased mortality rates to modern levels in just 100 years, researchers found.

In Japan, 72 has become the new 30, as the likelihood of a 72-year-old modern-day person dying is the same as a 30-year-old hunter-gatherer ancestor who lived 1.3 million years ago. Though the researchers didn't specifically look at the United States, they say the trends are not country-specific and not based in genetics.

Quick jump in life span

The same progress of decreasing average probability of dying at a certain age in hunters-gatherers that took 1.3 million years to achieve was made in 30 years during the 21st century.

"I pictured a more gradual transition from a hunter-gatherer mortality profile to something like we have today, rather than this big jump, most of which occurred in the last four generations, to me that was surprise," lead author Oskar Burger, postdoctoral fellow at the Max Planck Institute for Demographic Research in Germany, told LiveScience.

Biologists have lengthened life spans of worms, fruit flies and mice in labs by selectively breeding for old-age survivorship or tweaking their endocrine system, a network of glands that affects every cell in the body. However, the longevity gained in humans over the past four generations is even greater than can be created in labs, researchers concluded. [Extending Life: 7 Ways to Live Past 100]

Genetics vs. environment

In the new work, Burger and colleagues analyzed previously published mortality data from Sweden, France and Japan, from present-day hunter-gatherers and from wild chimpanzees, the closet living relative to humans.

Excerpt from:

Human Life Span Took Huge Jump in Past Century

Genetics Society of America Announces 2013 Award Recipients

Newswise BETHESDA, MD -- October 15, 2012 -- The Genetics Society of America (GSA) is pleased to announce its 2013 award recipients. The five individuals honored are recognized by their peers for their outstanding achievements and contributions to the community of geneticists. They will receive their awards at GSA conferences during 2013.

This years award winners are an outstanding group of individuals who have all contributed in such powerful ways to the field of genetics in research, in education, and in fostering the genetics community. The GSA awards provide an opportunity for the genetics community as a whole to say a heartfelt thank you and to recognize those whose impressive achievements have advanced the science of genetics, said Phil Heiter, PhD, President of GSA.

The recipients of the 2013 GSA Awards are as follows:

Thomas D. Petes, PhD (Duke University) is awarded the Thomas Hunt Morgan Medal for lifetime contributions in the field of genetics.

Elaine A. Ostrander, PhD (National Institutes of Health, National Human Genome Research Institute) is awarded the Genetics Society of America Medal for outstanding contributions to the field of genetics in the last 15 years.

R. Scott Hawley, PhD (Stowers Institute for Medical Research) is awarded the George W. Beadle Award for outstanding contributions to the community of genetics researchers.

A. Malcolm Campbell, PhD (Davidson College) is awarded the Elizabeth W. Jones Award for Excellence in Education, which recognizes significant and sustained impact in genetics education.

Jonathan K. Pritchard, PhD (HHMI and University of Chicago) is awarded the Edward Novitski Prize, which recognizes an extraordinary level of creativity and intellectual ingenuity in solving a significant problem in genetics research. Additional information about each of the awards and the recipients achievement is listed below.

Recipient: Thomas D. Petes, PhD, Duke University Award: The Thomas Hunt Morgan Medal

Dr. Petes is the Minnie Geller Professor in Genetics in the Department of Molecular Genetics and Microbiology at Duke University Medical Center in Durham, NC. He has made seminal research contributions that have furthered the understanding of the mechanisms of DNA damage and repair using the yeast Saccharomyces cerevisiae as a model system. His insights into comprehending genome stability and instability extend far beyond this model system, laying the foundation for much of our knowledge about how human cells replicate, protect, repair and combine their chromosomes. This has provided crucial understanding in identifying the gene defects of the most common form of hereditary colon cancer and in other human diseases.

See original here:

Genetics Society of America Announces 2013 Award Recipients

Myriad Genetics to Announce First Fiscal Quarter 2013 Results on Monday, November 5, 2012

SALT LAKE CITY, Oct. 15, 2012 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (MYGN) today announced that it will issue financial results for the first fiscal quarter 2013 following the close of market on Monday, November 5, 2012.

The Company will also host a conference call on Monday, November 5, 2012 at 4:30 P.M. Eastern to review the financial results. Participating on the call will be: Peter Meldrum, President and Chief Executive Officer, Mark Capone, President of Myriad Genetic Laboratories, Inc. and Jim Evans, Chief Financial Officer.

To listen to the call, interested parties may dial 800-354-6885 or 303-223-2680. All callers will be asked to reference reservation number 21607424.

The conference call will also be available through a live webcast at http://www.myriad.com.

A replay of the call will be available two hours after the end of the call for seven days and may be accessed by dialing 800-633-8284 or 402-977-9140 and entering reservation number 21607424.

About Myriad Genetics

Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patient's lives through the discovery and commercialization of transformative tests to assess a person's risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. Myriad's portfolio of molecular diagnostic tests are based on an understanding of the role genes play in human disease and were developed with a commitment to improving an individual's decision making process for monitoring and treating disease. Myriad is focused on strategic directives to introduce new products, including companion diagnostics, as well as expanding internationally. For more information on how Myriad is making a difference, please visit the Company's website: http://www.myriad.com

Myriad, the Myriad logo, BRACAnalysis, Colaris, Colaris AP, Melaris, TheraGuide, Prezeon, OnDose, Panexia and Prolaris are trademarks or registered trademarks of Myriad Genetics, Inc. in the United States and foreign countries. MYGN-F, MYGN-G

Visit link:

Myriad Genetics to Announce First Fiscal Quarter 2013 Results on Monday, November 5, 2012

Petes Wins Lifetime Achievement Award in Genetics

By Duke Medicine News and Communications

Thomas D. Petes, PhD, has been named the 2013 recipient of the Thomas Hunt Morgan Medal for lifetime achievement in the field of genetics from the Genetics Society of America. Petes, the Minnie Geller Professor of Molecular Genetics and Microbiology at Duke University School of Medicine, specializes in the study of yeast as a model for understanding genomic instability and chromosomal abnormalities commonly found in cancer cells. "Tom Petes research on cell division in yeast has direct relevance for human cells and the proteins involved in DNA repair, with important implications for understanding genetic defects that cause cancer," said Nancy Andrews, M.D., PhD., dean of the Duke University School of Medicine. "It is a powerful example of how the most fundamental, basic science research can have tremendous importance for understanding and treating human diseases. Petes and his colleagues have discovered striking similarities between yeast and human cells in the structure and function of proteins involved in DNA repair and in the protection of the tips of chromosomes. The similarities have yielded new insight into how normal cells become cancerous. For example, yeast cells lacking particular DNA mismatch repair enzymes exhibit genetic instabilities also found in human colorectal cancer cells, a finding that suggested the repair defects might play an important role in the disease process. Notably, Petes was among the first to apply these findings to hereditary non-polyposis colon cancer, an inherited syndrome in which 80 percent of patients develop intestinal tumors. Petes predicted that afflicted patients might similarly have mismatch repair mutations. The Petes lab also identified a gene in yeast required for maintenance of the tips of chromosomes that was closely related to a human gene mutated in patients with the cancer-prone disease ataxia telangiectasia. "Dr. Petes' rigorous work over the years in a model organism, in this case, yeast, is a wonderful example of how studies of model organisms can inform us about mechanisms of human disease, in this case, cancer, said Michael B. Kastan, M.D., PhD, executive director of the Duke Cancer Institute and the William W. Shingleton Professor of Pharmacology and Cancer Biology. He is richly deserving of this award for a superior body of work." Petes received his PhD in genetics at the University of Washington in Seattle. He then went on to postdoctoral fellowships at the National Institute for Medical Research in London and the Massachusetts Institute of Technology in Cambridge. In 2002, Petes served as president of the Genetics Society of America, and was the chair of the Department of Molecular Genetics and Microbiology at Duke from 2004-2009. He has been a member of the National Academy of Sciences since 1999; was named to the American Academy of Arts & Sciences in 2005; and became a fellow in the American Academy of Microbiology in 2009. The Thomas Hunt Morgan Medal is awarded for lifetime contributions to the science of genetics. It recognizes the full body of work of an exceptional geneticist, and recipients have made substantial contributions throughout their careers. The Medal was established by the Genetics Society of America in 1981 and named in honor of Thomas Hunt Morgan, who received a 1933 Nobel Prize for his findings, which provided the first experimental evidence that chromosomes are the carriers of genetic information.

Read the original:

Petes Wins Lifetime Achievement Award in Genetics

Master-builder of the Human Genetics Unit

Walking up the stairs of the Faculty of Medicine, which reminded me of a colonial English Mansion with an imposing regal atmosphere, I finally found the Office of the Dean.

In his spacious office sat Professor Rohan W. Jayasekara, Dean of the Faculty of Medicine who is a pioneer in the field of Medical Genetics in Sri Lanka. He is the person who established the first Human Genetics Unit in the country in 1983. Professor Jayasekara appeared to be extremely affable with a most friendly disposition and he immediately put one at ease. This is his interview with Reminiscences of Gold.

Professor Rohan Jayasekara

I was born in Colombo and had my upbringing in Mount Lavinia. I was the only child in the family. The childhood I spent in the early 50s was a laid back setup where things moved at a leisurely pace. Children got their education but at the same time they enjoyed their childhood. School began at 8.45 am and finished at 3.15 in the afternoon. So after a good breakfast, we went to school with a lunch break of one hour from 12.15pm - 1.15pm. We could even play a cricket match continuing the next day. Classes finished at 3.15 pm and those who wanted to play sports could stay on in the college.

Others came home and played the usual cricket, rugby and football in our garden. All the neighbours were one family. My father was an old Peterite so he sent me to St. Peters. There was strict discipline at St. Peters but at the same time there was a lot of freedom and we had a proper moulding. I owe so much to my old school. The important thing during that era was that we didnt have television. I remember coming to the British Council very regularly because I used to finish two books every week. We developed our reading habits which helped improve our command of the language, explained Jayasekara.

He joined the Faculty of Medicine at the Peradeniya University in 1967 where he spent five years. Those were the best years of my life and it was one of the most beautiful universities in the world. We had a balanced life. We thoroughly enjoyed seeing plays in the Open Arts Theatre. There were very dedicated teachers and there were the likes of Professor Bibile who had musical evenings in their homes. It was an enriching experience. I always felt that the graduates of Peradeniya had a kindred spirit. Maybe because we lived together, ate and drank together, enjoyed, celebrated and cried together. The 1971 JVP insurrection was the only tragic experience we had. Some lost their lives.

Jayasekera joined the Faculty of Medicine as a lecturer in 1974. He left the island in 1977 for his postgraduate studies at the Department of Human Genetics, University of Newcastle upon Tyne. Its a beautiful university town with friendly people. We learnt not only the subject matter but also other character moulding traits: how to communicate with people, how to be polite and how to disagree with people and how to control oneself. I have never seen any British professional throwing tantrums. Not even under the harshest of provocations. I have never seen my boss losing his temper. They had a way about them.

I had a very interesting experience during my stay in England. Besides my Ph.D. certificate, I also have a certificate from the Chief Constable of Northern England, the equivalent of our IGP there because I helped them arrest red handed a gang of car thieves. I used to work on the fourth floor of the Human Genetics Unit from where I could see the car park. One day I looked down at the car park and saw my car there. Fifteen minutes later I noticed that my red car was missing. So I phoned the Police. A week later they came home and knocked on the door and the people in my flat thought that I had committed a crime. My car had been found in Glasgow because some football hooligans had taken it there. It had been full of empty bottles of beer. A few months later, when I was looking down at the car park, I saw some guys trying to open some cars in the car park. I quickly rang the cops, and in five minutes, four panda cars rushed in and they caught the thieves red handed. Then they came up to the fourth floor looking for Dr. J and I identified myself. Three weeks later I got a letter from the Chief of Police saying : we greatly appreciate your action which helped us in arresting the car thieves and breaking a ring of crime that has been going on there. My boss Professor Roberts said: Chum, this is more valuable than your Ph.D. certificate. I felt happy because I did something good for the community.

Jayasekara returned to the island in 1980 having obtained a Ph.D. in Cytogenetics, which was a pioneering field at the time. The study of Human Genetics has far-reaching consequences for the health of any nation. Jayasekara established the first Human Genetics Unit in the country in 1983. When I came back from England, I was determined not to waste my knowledge and skills so I decided to start the unit. With the initial assistance of the WHO, I managed to build it up. Now we have collaborations and link programmes with several institutes abroad. We conduct teaching programmes for other faculties, institutes and colleges.

We have trained five doctors as clinical geneticists. Now it can run on its own and it is quite independent. I dont even have to sight the place because it is running really well. Im blessed with good people. Now there are 30 people in the unit. Our biggest problem is the lack of space and that is the only constraint. We have an abundance of talent. People are enthusiastic and they need to be encouraged and nurtured. Our talent is unmatched anywhere in the world. So my ambition is to see that every main town has a Human Genetics Unit.

The rest is here:

Master-builder of the Human Genetics Unit

Why You Should Care: US wastes $750 bln on health care (E23) – Video

14-10-2012 06:04 Americans are going broke paying for healthcare but their money is being wasted, especially by Tim's chrome creation. But will Tim be able to teach him remorse? Find out now! Tim Kirby's channel: Why You Should Care on our website: Why You Should Care on YouTube: Subscribe to RT! Like us on Facebook Follow us on Twitter Follow us on Google+ RT (Russia Today) is a global news network broadcasting from Moscow and Washington studios. RT is the first news channel to break the 500 million YouTube views benchmark.

Read the original:

Why You Should Care: US wastes $750 bln on health care (E23) - Video

Senate candidates debate health care overhaul

This is part of a series of stories on issues in the local congressional races, leading up to the election next month. This story focuses on health care. Future stories will look at Social Security, Medicare, federal spending and defense cuts.

U.S. Sen. Bob Casey is the Democrat running for re-election, Tom Smith is the Republican who wants his job and President Barack Obama's national health care reform law highlights their divide perfectly.

Casey proudly voted for the law; Smith wants to repeal it at all costs.

"It was the right vote," Casey said.

"I think it's the most intrusive invasion of personal rights that I've seen in my lifetime," Smith said.

As the two crisscross the state campaigning, the Patient Protection and Affordable Care Act, also known as Obamacare, looms as a major issue.

Then, there's Rayburn Smith, the Libertarian Party candidate, who says he would have opposed the law, and has his own idea of what to do about ensure health care coverage for all Americans.

Signed into law by President Obama on March 23, 2010, the Affordable Care Act aimed to expand health care coverage to an estimated 32 million uninsured Americans, but it comes with plenty of other provisions, some likable, some quite controversial.

Topping the list of the controversial: a requirement that everyone have health insurance and penalties for those who don't, a mandate upheld by the Supreme Court in June.

Among the favorites: elimination of three-quarters of the gap in senior citizen prescription drug coverage by 2020, a prohibition on insurance companies denying anyone coverage for pre-existing conditions and letting children stay on their parent's health insurance plans until age 26.

Read the original here:

Senate candidates debate health care overhaul

First-Ever Forbes Health Care Conference To Focus On Transparency And Transformation

For the past few months, I've been working on a big project with a team of some of the smartest people at Forbes ? our first-ever health care conference, hosted by Steve Forbes himself. It will be held here in New York City on the evening of December 4 and all day on December 5. Click here for the conference website.

Read more from the original source:

First-Ever Forbes Health Care Conference To Focus On Transparency And Transformation

Philips Respironics improves health care delivery and quality of life for sleep and respiratory patients

ATLANTA, Oct. 16, 2012 /PRNewswire/ --Philips Respironics, a unit of Royal Philips Electronics (NYSE: PHG, AEX: PHI), today at Medtrade 2012 showcases advancements that allow patients to sleep and breathe easier, demonstrating its commitment to improving the quality of life of those who suffer from chronic sleep and respiratory conditions. Medtrade, taking place this week at the Georgia World Congress Center, is the nation's largest conference and exposition focused exclusively on the home medical equipment (HME) industry.

(Logo: http://photos.prnewswire.com/prnh/20110726/NY41282LOGO )

At Medtrade 2012, Philips Respironics will offer homecare providers a first-hand look at solutions that treat and manage conditions that affect millions of Americans each year such as obstructive sleep apnea (OSA), chronic obstructive pulmonary disease (COPD) and asthma. Designed with the patient in mind, these new solutions bring quality care into the home, enabling those with sleep and respiratory conditions to maintain their freedom and independence. Philips Respironics will offer an interactive experience with multimedia displays, hands-on demonstrations and docent tours of its new products and programs.

"The role of the homecare provider has never been more critical," says John Frank, senior vice president, general manager, Sleep and Respiratory Care, Philips Home Healthcare Solutions. "We are committed to helping homecare providers enhance patients' lives by delivering cost-effective solutions that drive better treatment, monitoring and management of their conditions. We are working together with all stakeholders to navigate through the changes in the new era of health care."

Some of the new offerings that Philips Respironics will be highlighting include:

- Fit for Life specialized resupply mask solution

Fit for Life, a comprehensive mask and service program, gives providers a way to offer their patients easy and reliable access to important replacement masks, supplies and resources they need to benefit from their OSA therapy. It also offers simple ways for homecare providers to monitor and document compliance with major commercial and public insurance providers' eligibility requirements and the recently released Centers for Medicare and Medicaid Services' (CMS) resupply policy clarification.

"We now have a comprehensive program to help providers meet the needs of their OSA patients through a lifetime of care, while effectively coordinating payer and industry requirements," said Mr. Frank. "Fit for Life acknowledges the operational and economic forces that are shaping the industry and is another example of our commitment to the industry. The program is a natural complement to our growing portfolio of masks."

- Wisp minimal contact hybrid nasal mask (coming soon)

The Wisp minimal contact nasal mask, a hybrid nasal/pillow mask that offers the emotional appeal and benefits of a low profile mask with best in class performance, delivers in four key areas: comfort, ease of use, visual appeal and the ability to fit a wide range of patients. The modular frame comes in two styles that patients can switch between: a reversible fabric and clear silicon. This allows patients to watch television or read a book before going to bed, making it easy to live with.

Read this article:

Philips Respironics improves health care delivery and quality of life for sleep and respiratory patients

Noticeable difference between Quebecers' and other Canadians' perspectives on factors affecting health

http://www.conferenceboard.ca

OTTAWA, Oct. 16, 2012 /CNW/ - Compared to Canadians in other provinces, Quebecers put more emphasis on the health care system and less on daily activities as the factors having the biggest impact on a person's health, according to an EKOS Research Associates survey released by The Conference Board of Canada today.

"The differences between Quebecers and the national results are slight on most of the individual questions, but, when the survey results are taken as a whole, there is a noticeable difference in perspectives," said Louis Thriault, Director, Health Economics.

When asked to identify the factor that has the biggest impact on the health of the average Canadian, 39 per cent of Quebecers selected daily activities, more than any other factor. Nationally, 48 per cent of survey respondents said daily activities had the biggest impact on a person's health. This figure rose to 60 per cent of respondents in Alberta.

Quebecers were most likely to say that the health care system had the biggest impact on the health of Canadians (21 percent versus 17 per cent nationally). Quebecers were also the most likely respondents in the country to say that food, water and environmental factors had the biggest impact on personal health.

Quebecers considered environmental factors marginally more important than respondents elsewhere in Canada (87 per cent versus 85 per cent nationally) and they were somewhat more likely to see income as an important factor (69 per cent versus 63 per cent nationally).

When asked how important lifestyle factors are to their health: Physical activity: 76 per cent of the national population said being physically active was very important to their health, compared to 71 per cent of Quebecers; Diet and nutrition: 74 per cent of respondents nationally said it was very important to eat a well-balanced diet, compared to 52 per cent of Quebecers; Smoking: Nationally, 82 per cent of respondents said not smoking is very important to their health, a sentiment shared by 79 per cent of Quebecers; Alcohol consumption: 44 per cent for respondents nationally said it was very important not to drink too much alcohol; 37 per cent of Quebecers agreed.

EKOS Research Associates conducted this study to update and refine the understanding of Canadian views on health and the health care system. The methodology involved a nationally representative survey of 2,047 Canadians 18 years of age and older - 519 were surveyed by telephone and 1,528 completed the survey online. The sample source for this study was members of the EKOS panel, which was specifically designed for online/telephone surveys, Results include a margin of errors of plus or minus 2.2 per cent 19 times out of 20. The survey took place in May 2012, and the findings will be released throughout October and November 2012.

The study was supported by the Canadian Medical Association, Accreditation Canada and the Conference Board's Canadian Alliance for Sustainable Health Care (CASHC). Launched in 2011, CASHC is a five-year Conference Board program of research and dialogue. It will delve deeply into facets of Canada's health care challenge, including the financial, workplace, and institutional dimensions, in an effort to develop forward-looking qualitative and quantitative analysis and solutions to make the system more sustainable.

As part of the CASHC initiative, the Conference Board is hosting the Summit on Sustainable Health and Health Care in Toronto on October 30 and 31. The Summit will bring together Canada's health system leaders to discuss the latest research, learn from top Canadian experts, and explore solutions for Canada's greatest health challenges and opportunities.

Read the rest here:

Noticeable difference between Quebecers' and other Canadians' perspectives on factors affecting health

UMass Memorial Health Care Teams Up with Informatica and MedCPU on Innovative Solution for Reducing Preventable …

WORCESTER, Mass.--(BUSINESS WIRE)--

UMass Memorial Healthcare (UMMHC), the largest health care system in Central New England, is implementing innovative technology to reduce the frequency of preventable readmissions as per the Centers for Medicare and Medicaid Services Readmissions Reduction Program. The new UMMHC Readmissions Reduction Initiative will cover the entire inpatient and ambulatory environments of UMMHC, including all its affiliated physicians, their outpatient offices and their patients.

The ability to accurately monitor patients clinical status and identify, in real-time, any administrative or clinical deficiencies in patients care that might increase the risk of avoidable readmission, is critical for our success in fighting the readmissions challenge, said George Brenckle, PhD, senior vice president and chief information officer at UMass Memorial Healthcare. Theres so much information about the patient, spread over multiple systems and multiple formats, that only with advanced technology that can consolidate it all into an accurate discrete snapshot of the patients clinical picture, we can provide significant assistance to our clinicians and case managers in maximizing our efforts for better patient care.

UMass Memorial teamed with two technology companies, Informatica and MedCPU, to create a complete Readmissions Reduction initiative. The solution provides full administrative and clinical support, in one application, to providers, care managers and patients in managing and reducing avoidable readmissions. The solution:

With the Readmissions Reduction legislation recently coming into effect, it is imperative that UMass Memorial Healthcare have access to the most accurate and trustworthy data to ensure the best patient care possible, said Richard Cramer, chief healthcare strategist, Informatica. By partnering with MedCPU to address the readmission challenge, weve been able to offer a comprehensive solution that identifies high-risk patients and focuses on intervention and proactive medicine.

Our collaboration with Informatica enables us to deliver a highly accurate and efficient prompting system that overcomes one of the most difficult hurdles in healthcare significant loss of information due to narrative documentation by clinicians, said Eyal Ephrat, M.D., MedCPU CEO and co-founder. UMass Memorial Health Care led us to a highly significant goal of creating a reliable solution that gains the clinicians respect for its accuracy and proficiency in promoting better patient care. We have strong confidence that our partnership shall deliver these expectations, and beyond.

About UMass Memorial Health Care

UMass Memorial Health Care is Central Massachusetts' largest not-for-profit health care delivery system, covering the complete health care continuum with UMass Memorial Medical Center, its academic medical center, member and affiliated community hospitals, freestanding primary care practices, ambulatory outpatient clinics, a rehabilitation group and mental health services. UMass Memorial is the clinical partner of the University of Massachusetts Medical School. To learn more about UMass Memorial, please visit http://www.umassmemorial.org, Facebook, Twitter and YouTube.

About MedCPU:

MedCPU delivers accurate real-time clinical care advice through its revolutionary Advisor Button technology. It uniquely captures the complete clinical picture from clinicians free-text notes, dictations and structured documentation entered into any EMR, and analyzes it against a growing library of best-practice content, generating real-time precise prompts for best care consideration. MedCPUs founding multi-disciplinary team has been leading the field of real-time clinical decision support for over 17 years, delivering intelligent error reduction software systems to many hospitals in the US. MedCPU applications include clinical and compliance support solutions. For more information, visit http://www.MedCPU.com

See the original post:

UMass Memorial Health Care Teams Up with Informatica and MedCPU on Innovative Solution for Reducing Preventable ...

Health-care Stocks: J&J, UnitedHealth get a lift from earnings reports

By Russ Britt, MarketWatch

LOS ANGELES (MarketWatch) Two health-care giants, Johnson & Johnson and UnitedHealth Group Inc., moved higher Tuesday after the companies reported third-quarter earnings that beat analyst estimates.

Shares of Johnson & Johnson /quotes/zigman/230812/quotes/nls/jnj JNJ +1.28% got the boost that many investors were looking for, climbing more than a buck at one point as the health-care conglomerate said adjusted third-quarter earnings were $1.25 a share. That was ahead of the FactSet consensus of analyst estimates, which came in at $1.19 a share.

Citigroup Chief Executive Vikram Pandit is stepping down, effective immediately, and will be succeeded by Michael Corbat.

J&J said net income for the quarter was $2.63 billion, or $1.05 per share including one-time charges, compared with $3.2 billion, or $1.15 a share, for the same period a year ago. Sales were $17.1 billion against last years $16 billion. The FactSet consensus called for sales of $17.5 billion, though analysts said the Street consensus was closer to $17 billion, meaning the company came in ahead of forecasts.

J&J also increased its own forecast for full-year results, saying that 2012 earnings should come in at $5.05 to $5.10 a share, up from its earlier prediction of $5.00 to $5.07 a share.

J&J shares should trade higher today in reaction to what we view as a strong, basically clean quarterly beat, Leerink Swann analyst Danielle Antalffy said in a note to clients.

J&J shares were up 78 cents, or 1.1%, to $69.38 in recent action.

UnitedHealth /quotes/zigman/258846/quotes/nls/unh UNH -1.11% , meanwhile, had a similar earnings report but it wasnt as surprising to investors, and so the share boost wasnt as great. UnitedHealth previewed its earnings recently. Shares were up marginally to $57.67 in recent action.

The company said net income was $1.56 billion, or $1.50 a share, compared with $1.27 billion, or $1.17 a share. Revenue for the health-insurance behemoth was $27.3 billion against last years $25.3 billion. Analysts said they had expected the company would earn $1.34 a share.

See the original post:

Health-care Stocks: J&J, UnitedHealth get a lift from earnings reports

Health Care Service Corporation And Loveisrespect Announce Initiative To Educate One Million Teens On Teen Dating …

CHICAGO, Oct. 16, 2012 /PRNewswire/ -- Health Care Service Corporation (HCSC), the nation's largest customer-owned health insurer, and Loveisrespect, the ultimate source of support for young people to prevent and end dating abuse, announce an initiative to educate one million teens on teen dating abuse and prevention.

HCSC, operator of Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas, and Loveisrespect's new collaboration will reduce the growing epidemic of teen dating violence with tailored, on-the-ground outreach and awareness programs that will better equip our schools, families and communities with the information and resources needed to respond to this issue. According to multiple studies, one in three adolescents in the U.S. is a victim of physical, sexual, emotional or verbal abuse from a dating partner a figure that far exceeds rates of other types of youth violence and nearly 1.5 million high school students experience physical abuse from a dating partner in a single year.

Through this alliance, communities in Illinois, New Mexico, Oklahoma and Texas will learn to identify the warning signs and better respond to teen dating violence through the creation of school-based initiatives such as "Loveisrespect Institutes." As many as 1,000 free toolkits, the largest single distribution of its kind, will be sent out and will include a curriculum which leverages technology to provide teachers with web-based activities and methods for creating a supportive community.

"As a result of HCSC's support, our innovative service-learning programs will help young people develop healthy definitions of positive relationships. We're creating, conducting, evaluating and distributing a comprehensive dating abuse prevention program that will lead to measurable successes," said Cristina Escobar, director of Loveisrespect.

"We are honored to have an opportunity to team with other organizations who share our commitment to creating pathways for teenagers, their families and friends to build relationships of warmth, mutual respect and love," said Conway McDanald, chief medical officer, behavioral health, HCSC. "In our initative with Loveisrespect, we have tailored the program to our states to spread awareness and provide support to prevent teen dating violence and abuse. The collective impact creates a safe space for teens to talk about things that may be difficult and helps them decide when and where they want to do it, at any time, using any mode of communication they choose."

This program is in conjunction with Healthy Kids, Healthy Families (HKHF), a three-year initiative with a goal of improving the health and wellness of at least one million children in four states, Illinois, New Mexico, Oklahoma and Texas.

The HKHF initiative invests in and partners with nonprofit organizations that offer sustainable, measurable programs to reach children and their families in four pillar categories including supporting safe environments, nutrition education, physical activity, and disease prevention and management. Overall, the Healthy Kids, Healthy Families initiative reflects HCSC's commitment to make a meaningful difference across all of the areas we serve. Within the first year, the HKHF initiative granted more than $6 million to more than 90 community partners across the four states it serves. Currently in the second year of the initiative, funding decisions and new partnerships are being identified across our four states. Additional "Healthy Kids, Healthy Families" pillar partners include:

About Health Care Service Corporation Health Care Service Corporation is the country's largest customer-owned health insurer and fourth largest health insurer overall, with more than 13 million members in its Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas. A Mutual Legal Reserve Company, HCSC is an independent licensee of the Blue Cross and Blue Shield Association. For more information, please visit http://www.HCSC.com, visit our Facebook page or follow us at http://www.twitter.com/HCSC.

About Healthy Kids, Healthy Families Healthy Kids, Healthy Families is a three-year initiative designed to improve the health and wellness of at least one million children through community investments by Health Care Service Corporation and its Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas. The initiative will invest in and partner with nonprofit organizations that offer sustainable, measurable programs to reach children and their families in areas of nutrition education, physical activity, disease prevention and management, and supporting safe environments. To learn more about Health Kids, Healthy Families, please visit http://www.healthykidshealthyfamiles.org.

About Loveisrespect Loveisrespect helps teens and young adults, ages 13-24 navigate the spectrum of healthy relationship behaviors. From the program, young people learn there are options, answers and support available to them every hour of every day. Forming the national partnership to end dating abuse, Break the Cycle and the National Dating Abuse Helpline designed the new loveisrespect specifically for young people, emphasizing confidentiality and trust to ensure teens and 20-somethings nationwide feel safe and supported online and off. Find out more at http://www.loveisrespect.org.

See the article here:

Health Care Service Corporation And Loveisrespect Announce Initiative To Educate One Million Teens On Teen Dating ...

Discovering genetic associations using large data

David Heckerman from Microsoft Research presents a summary of his work in the session Discovering Genetic Associations on Large Data. This was part of the Strata Rx Online Conference: Personalized Medicine, a preview of OReillys conference Strata Rx, highlighting the use of data in medical research and delivery.

Heckermans research attempts to answer essential questions such as What is your propensity for getting a particular disease? and How are you likely to react to a particular drug?

Key points from Heckermans presentation include:

The full presentation follows:

Related:

Read this article:

Discovering genetic associations using large data

23andMe Compares Family History and Genetic Tests for Predicting Complex Disease Risk

MOUNTAIN VIEW, Calif., Oct. 15, 2012 /PRNewswire/ --In a new theoretical study, 23andMe, the leading personal genetics company, developed a mathematical model which shows that family history and genetic tests offer different strengths. The study results suggest that both family history and genetics are best used in combination to improve disease risk prediction. The full results of the study have now been published online in the journal PLOS Genetics.

Family history is most useful in assessing risks for highly common, heritable conditions such as coronary artery disease. However, for diseases with moderate or low frequency, such as Crohn's disease, family history accounts for less than four percent of disease heritability and is substantially less predictive than genetic factors in the overall population. The study results indicate single nucleotide polymorphism (SNP)-based genetic tests can reveal extreme likelihood ratios for a relatively large percentage of individuals, thus providing potentially valuable evidence in differential diagnoses.

"Both family history and genetics are important tools for assessing an individual's risk for disease," 23andMe CEO and co-founder Anne Wojcicki said. "We believe it will become increasingly important for individuals and physicians to know both family history and genetic profile to provide optimal healthcare."

Lead author and 23andMe scientist Chuong Do, Ph.D, worked with 23andMe senior medical director Uta Francke, M.D., and principal scientists David Hinds, Ph.D., and Nicholas Eriksson Ph.D. to make a comprehensive comparison of family health histories and genetic testing to assess risk for 23 different conditions. These conditions included coronary artery and heart diseases, type 1 and 2 diabetes, prostate cancer, Alzheimer's disease, breast cancer, lung cancer, Crohn's and celiac disease, ovarian cancer, melanoma, bipolar disease and schizophrenia among others.

The analysis confirms that family history is most useful for highly common, heritable conditions and for single-gene (Mendelian) disorders with high penetrance, where the specific genetic cause is not yet known. For relatively common diseases that may have many contributing genetic and environmental factors, such as coronary artery disease, knowing that your father had the disease is helpful at predicting whether or not you might be at risk for the same condition.

For less common diseases involving many weak genetic, such as Crohn's disease, knowing family history seldom helps in making a risk prediction, in part, because these diseases are uncommon enough that they would rarely show up in the immediate family health history. When family histories are uninformative, genetic testing may still reveal the genetic variants that would put an individual at a higher or lower risk for the condition. For example, Crohn's disease might not show up in a family history, but the risk prediction from a genetic test can be relatively more informative.

"These results indicate that for a broad range of diseases, already identified SNP associations may be better predictors of risk than their family history-based counterparts, despite the large fraction of missing heritability that remains to be explained," stated lead researcher Chuong Do, Ph.D. "They also suggest that in some cases, individuals may benefit from supplementing their family medical history with genetic data, in particular, as genetic tests are improving and more risk factors are discovered."

"This study addresses the false division between these two diagnostic tools, genetic testing versus family health histories, where the approaches have traditionally been portrayed as competing alternatives," explained Uta Francke, M.D., senior medical director. "Physicians rely on a variety of tools such as a stethoscope or a thermometer both are useful in their own way. Similarly, family health histories and genetics both offer different but equally valuable information to inform patient care."

"Using genetic testing or SNP-association based methods to estimate risk for some rare complex diseases is as good as family histories can be at estimating risk for common heritable conditions," Dr. Francke continued, "and for individuals who don't have access to their family health history, genetic testing can alert them to risks they wouldn't be aware of otherwise."

The authors use their theoretical model to demonstrate the limits of predictive testing while also outlining specific areas where genetic tests have the potential to be medically useful. These results, which provide a cautiously optimistic outlook on the future of genetic testing, contrast with the conclusions reached in an independent study published earlier this year in Science Translational Medicine.

More:

23andMe Compares Family History and Genetic Tests for Predicting Complex Disease Risk

NextGxDx Launches Comprehensive Genetic Testing Platform, Curating Information on More Than 10,000 Genetic Testing …

NASHVILLE, Tenn., Oct. 16, 2012 /PRNewswire/ -- NextGxDx, a healthcare information technology company, today announced the release of its online genetic testing platform that curates information on the more than 10,000 genetic testing products currently offered by FDA and CLIA certified labs in the U.S. According to NextGxDx's research, the database is the most comprehensive catalog of all the genetic testing products available to U.S. healthcare providers. The company also found the number of available tests is tenfold greater than previously estimated by industry experts.

The company intends to help implement strategies that further clinical integration of genetic testing. The goal of the platform is to speed the process of diagnosing, and thus treating, patients with genetic diseases. The NextGxDx platform allows healthcare providers and hospitals to easily identify the appropriate genetic tests for their patients by searching the database by symptoms or browsing by clinical specialty. The platform also allows side-by-side comparison of tests, and the company's partnerships with laboratories across the country enable physicians to order tests directly from the NextGxDx website.

"Our research shows there are nearly ten times more genetic tests available today than commonly thought, and yet there has not been a centralized, well-curated, user-friendly platform to help healthcare providers find the right test for a patient. Our platform brings together all the disparate information about available genetic tests to help physicians find and order the best test the first time," said Mark Harris, Ph.D., founder and CEO of NextGxDx. "In addition to facilitating the diagnosis process, the technology we have developed will allow us to maintain the most accurate catalog of genetic testing products available."

NextGxDx explores the factors informing and shaping the industry in "The Genetic Testing Landscape: Finding the Needle in the Haystack" a white paper released today. The paper provides a comprehensive overview of the genetic testing industry, including the size of the industry, how genetic tests are used and how genetic information is communicated. It also outlines key strategies for the future of clinical integration of genetic testing and personalized medicine.

Among the paper's key findings:

"This report is designed to establish a robust analysis of genetic testing as it relates to the products currently available for clinical use," said Jud Schneider, Ph.D., scientific director of NextGxDx and author of the white paper. "As personalized medicine becomes a clinical reality, we think it's important for physicians to understand the scope and trajectory of the genetic testing industry and how it may impact their practices in the years ahead."

The white paper is currently available for free download on the NextGxDx website, http://www.NextGxDx.com.

About NextGxDx

NextGxDx is a healthcare information technology company that provides a web-based genetic diagnostics platform allowing hospitals and physicians to quickly and efficiently identify appropriate genetic tests and cross-reference multiple test providers. With the ability to research tests based on patient symptoms, instantly compare tests across laboratories, and determine existing institutional relationships, NextGxDx provides physicians with a single destination for discovering, comparing and ordering genetic tests. For more information, visit http://www.NextGxDx.com.

Media Contact: Erin Lawley 615-946-9914 erin@lovell.com

Originally posted here:

NextGxDx Launches Comprehensive Genetic Testing Platform, Curating Information on More Than 10,000 Genetic Testing ...